Definium Therapeutics is a late-stage clinical biopharmaceutical company focused on developing accessible treatments for psychiatric disorders using psychedelics. Our mission is to forge a new era of psychiatry by applying scientific rigor to psychedelics. Our lead product candidate, lysergide tartrate, is in development for generalized anxiety, major depressive disorder, and posttraumatic stress disorder. Our pipeline also includes DT402, targeting core symptoms of autism spectrum disorder. We aim to change the trajectory of mental health care by addressing the underlying causes of psychiatric and neurological disorders. Headquartered in New York, Definium Therapeutics trades on Nasdaq under the symbol DFTX. The Director, Patient Services Site of Care Strategy will be instrumental in developing and executing the Patient Services site of care strategy for the successful commercial launch of DT120. This role requires close collaboration with Regulatory, Marketing, Legal, and other commercial teams to align with corporate objectives. The position will lead site of care engagement strategy, encompassing onboarding, treatment preparation, REMS (Risk Evaluation and Mitigation Strategies), and ongoing support, ensuring adherence to stringent regulatory standards like those set by the FDA. A key responsibility is strategy creation and ensuring Definium field teams are well-equipped to engage with sites of care.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Director